Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 11—November 2002
Research

Tuberculosis-Related Deaths within a Well-Functioning DOTS Control Program

Maria de Lourdes García-García*, Alfredo Ponce-de-León†, Maria Cecilia García-Sancho‡, Leticia Ferreyra-Reyes*, Manuel Palacios-Martínez*, Javier Fuentes§, Midori Kato-Maeda†, Miriam Bobadilla†, Peter Small¶, and Jose Sifuentes-Osornio†
Author affiliations: *Instituto Nacional de Salud Pública, Cuernavaca, México; †Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán,” México City, México; ‡Instituto Nacional de Enfermedades Respiratorias, México City, Mexico; §Secretaría de Salud del Estado de Veracruz, Xalapa, México; ¶Stanford University, Palo Alto, California, USA;

Main Article

Table 2

Population attributable-risk percent and hazard ratios for death among smear-positive tuberculosis (TB) patients, Orizaba, Veracruz, 1995–2000a

Variables Population attributable risk (%) Adjusted
hazard ratio 95% CI p valueb
Death due to TBc
Treatment default 28.7 8.9 3.3 to 24.4 <0.0001
Resistance to isoniazid and rifampin 25.9 5.7 2.0 to 16.3 <0.001
Clustered 18.8 4.1 1.6 to 10.0 0.002
Weight loss (>15%) — 3.9 1.5 to 10.9 0.007
Formal education <6 yr — 1.8 0.6 to 5.2 0.3
Death due to other causes
HIV/AIDS 11.1 33.1 11.4 to 95.4 <0.0001
Hepatic cirrhosis 6.6 5.7 1.6 to 19.7 0.006
Weight loss (>15% ) — 3.3 1.6 to 6.7 0.001
Age (yrs) — 1.02 0.99 to 1.04 0.07

aCI, confidence interval; —, not applicable.
bCox proportional hazards model.
cControlling for death before or after treatment completion, default or failure.

Main Article

Page created: July 19, 2010
Page updated: July 19, 2010
Page reviewed: July 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external